GE HealthCare Technologies
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 2 weeks.
- Recent price momentum is +8.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 4.0% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation B
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 17.0x | Better than 51% |
| Forward P/E | 15.7x | Better than 53% |
| Price / Sales | 1.7x | Better than 63% |
| P/E vs own 5-yr range | 39th pctl | Better than 69% |
Growth C
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 4.0% | Better than 42% |
| Net income CAGR (3Y) | 2.8% | Better than 46% |
| Free cash flow CAGR (3Y) | -5.8% | Better than 32% |
Profitability B+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 40.0% | Better than 49% |
| Operating margin | 13.4% | Better than 61% |
| Net margin | 10.1% | Better than 60% |
| Return on equity | 22.1% | Better than 81% |
| Return on invested capital | 12.4% | Better than 76% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 7.8% | Better than 87% |
| 6-month return | 25.6% | Better than 87% |
| 12-month return (ex latest month) | -6.4% | Better than 26% |
| Distance below 52-week high | 10.0% | Better than 84% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.4x | Better than 36% |
| Debt to assets | 28.4% | Better than 43% |
| Interest coverage | 7.3x | Better than 66% |
| Free cash flow / net income | 72.2% | Better than 23% |
Analyst View C-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 64.3% | Better than 40% |
| Upside to average target | 8.3% | Better than 12% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 81.89
- Open
- 82.50
- Day range
- 80.29 - 83.07
- Avg price
- 80.98
- Volume
- 3.77M
- Turnover
- 305.38M
- Turnover ratei
- 0.84%
- Volume ratioi
- 1.23
- Amplitudei
- 3.40%
- 52-week rangei
- 58.68 - 89.59
Valuation
- P/Ei
- 17.72
- P/E (TTM)i
- 17.05
- P/Bi
- 3.14
- EPSi
- 4.55
- Book value / shi
- 25.69
- Net profit
- 2.06B
- Net assets
- 11.61B
Share structure
- Market cap
- 36.46B
- Float capi
- 36.34B
- Shares out
- 452.14M
- Float sharesi
- 450.67M
Dividend & listing
- Div yield (TTM)i
- 0.17%
- Dividend (TTM)
- 0.14
- Listing date
- 2022-12-15
10.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-34.60M net over the window
Short interest
- Shares short
- 18.26M
- % of floati
- 4.04%
- Days to coveri
- 4.87
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of GE HealthCare Technologies (GEHC)?
GE HealthCare Technologies last traded at 80.64. This page shows a periodic quote snapshot. Check the displayed quote time.
What is GE HealthCare Technologies's market cap?
About 36.46B.
What is the P/E ratio of GE HealthCare Technologies?
The trailing twelve-month P/E is 17.05, below its own 5-year average of 19.36 — in the middle of its historical range (39.31% percentile). See the Valuation tab for the full history.
Does GE HealthCare Technologies pay a dividend?
Yes. The trailing dividend yield is 0.17%. The 2025 payout was up 16.7% from 2024. See the Dividends tab for the full payment history.
Is GE HealthCare Technologies a buy according to analysts?
The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 87.36, which implies 8.3% upside from the current price. This is not investment advice.
What is GE HealthCare Technologies's StockVane Quant Rating?
The StockVane Momentum strategy currently rates GE HealthCare Technologies a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
GE HealthCare Technologies discussion 0 comments